ESPERITE (Netherlands) Today

Equity ratings for ESPERITE are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of April 2021 and ending today, the 24th of July 2021. Click here to learn more.
ESPERITE cannot be verified against its exchange. It appears that ESPERITE is not available for investing at the moment. Please verify the symbol is currently traded on Amsterdam Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

ESPERITE Stock Profile

Esperite N.V., together with its subsidiaries, operates as a regenerative and predictive medicine company in the Netherlands, Spain, Italy, Switzerland, and internationally. Esperite N.V. was founded in 2000 and is headquartered in Amsterdam, the Netherlands. ESPERITE operates under Healthcare Services classification in Netherlands and is traded on Amsterdam Stock Exchange. It employs 133 people.. The public information regarding ESPERITE's current market price is not available at this time.
ESPERITE is not yet fully synchronised with the market data
ESPERITE has some characteristics of a very speculative penny stock
ESPERITE has high likelihood to experience some financial distress in the next 2 years
ESPERITE has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company has accumulated 4.55 M in total debt with debt to equity ratio (D/E) of 630.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ESPERITE has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported the revenue of 13.57 M. Net Loss for the year was (18.72 M) with profit before overhead, payroll, taxes, and interest of 10.9 M.
ESPERITE has accumulated about 1.34 M in cash with (5.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Legal NameESPERITE
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ESPERITE's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
ESPERITE (ESP) is traded on Amsterdam Stock Exchange in Netherlands and employs 133 people. The company currently falls under 'Nano-Cap' category with current market capitalization of 2.27 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ESPERITE's market, we take the total number of its shares issued and multiply it by ESPERITE's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. ESPERITE operates under Healthcare sector and is part of Medical Care industry. The entity has 34.78 M outstanding shares. ESPERITE has accumulated about 1.34 M in cash with (5.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check ESPERITE Probability Of Bankruptcy

ESPERITE Stock Against Markets

Picking the right benchmark for ESPERITE stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ESPERITE stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ESPERITE is critical whether you are bullish or bearish towards ESPERITE at a given time.
ESPERITE cannot be verified against its exchange. It appears that ESPERITE is not available for investing at the moment. Please verify the symbol is currently traded on Amsterdam Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ESPERITE stock to make a market-neutral strategy. Peer analysis of ESPERITE could also be used in its relative valuation, which is a method of valuing ESPERITE by comparing valuation metrics with similar companies.
Check out Investing Opportunities. Note that the ESPERITE information on this page should be used as a complementary analysis to other ESPERITE's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Tools for ESPERITE Stock

When running ESPERITE price analysis, check to measure ESPERITE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESPERITE is operating at the current time. Most of ESPERITE's value examination focuses on studying past and present price action to predict the probability of ESPERITE's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ESPERITE's price. Additionally, you may evaluate how the addition of ESPERITE to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go